Skip to main content
OpenTrials

Clinical trial condition

Genetic Diseases, Inborn

Explore clinical trials studying Genetic Diseases, Inborn. Study availability and eligibility vary by location and protocol.

12,677 public trials 2,140 recruiting studies
Refine in advanced search Browse all conditions

Genetic Diseases, Inborn trial results

Completed

Allogeneic ABCB5-positive Stem Cells for Treatment of Epidermolysis Bullosa

NCT03529877

Conditions
Collagen Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations
  • University of Minnesota, Masonic Cancer Center and Medical Center Minneapolis, Minnesota, United States
  • EB-Haus Austria; Salzburger Landeskliniken (SALK); Paracelsus Medizinische Privatuniversität Salzburg (PMU) Salzburg, Austria
  • Hôpital Saint-Louis; Département de dermatologie Paris, France
  • Department of Dermatology, Medical Center-University of Freiburg Freiburg im Breisgau, Germany
View Trial Details
Completed

Oral DS107 in Moderate to Severe Atopic Dermatitis

NCT02211417

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Dignity Sciences investigational site Arlington Heights, Illinois, United States
  • Dignity Sciences investigational site West Dundee, Illinois, United States
  • Dignity Sciences investigational site Warren, Michigan, United States
  • Dignity Sciences investigational site Verona, New Jersey, United States
View all 14 locations
View Trial Details
Completed

Study in Healthy Participants and Participants With Moderate Atopic Dermatitis & Optionally, Moderate Psoriasis, and/or Mild Asthma

NCT04927195

Conditions
Asthma, Atopic Dermatitis, Bronchial Diseases, +17 more
Locations
  • MAC Clinical Research Manchester Manchester, Greater Manchester, United Kingdom
  • Medicines Evaluation Unit (MEU) Manchester, Greater Manchester, United Kingdom
  • MAC Clinical Research Blackpool, Lancashire, United Kingdom
  • MAC Clinical Research Liverpool, Merseyside, United Kingdom
View Trial Details
Completed

Efficacy and Safety of Lanadelumab (SHP643) in Japanese Participants With Hereditary Angioedema (HAE)

NCT04180163

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Toyohashi Municipal Hospital Toyohashi, Aichi-ken, Japan
  • Asahi General Hospital Asahi-shi, Chiba, Japan
  • Ogaki Municipal Hospital Ogaki-shi, Gifu, Japan
  • Hiroshima University Hospital Hiroshima, Japan
View Trial Details

Related conditions